Michel Dahan - SVP, Chief Operating Officer at Akebia Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
SVP, Chief Operating Officer
Issuer Symbol
AKBA on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Michel Dahan since 14 Mar 2025

Holdings reported by Michel Dahan for Akebia Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 672,092 $846,836 $1.26 13 May 2024 Direct
Stock Option (Right to buy) 224,000 31 Jan 2024 Direct Common Stock

Transactions reported by Michel Dahan for Akebia Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.